The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran

MR Shafie Pour,1 T Sadeghiyeh,2 M Hadavi,3,4 M Besharati,5 R Bidaki61Department of Internal Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 2Department of Psychiatry, Research Center of Addiction and Behavioral Sciences, Hahid Sadoughi University of Medical Sciences, Yazd, Iran;...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shafie Pour MR, Sadeghiyeh T, Hadavi M, Besharati M, Bidaki R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Barriers Diabetes Insulin Therapy. Yazd Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/3482e4b07211459ebd9f284584131d49
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:3482e4b07211459ebd9f284584131d49
record_format	dspace
spelling	oai:doaj.org-article:3482e4b07211459ebd9f284584131d492021-12-02T11:32:46ZThe barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran1178-7007https://doaj.org/article/3482e4b07211459ebd9f284584131d492019-08-01T00:00:00Zhttps://www.dovepress.com/the-barriers-against-initiating-insulin-therapy-among-patients-with-di-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007MR Shafie Pour,1 T Sadeghiyeh,2 M Hadavi,3,4 M Besharati,5 R Bidaki61Department of Internal Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 2Department of Psychiatry, Research Center of Addiction and Behavioral Sciences, Hahid Sadoughi University of Medical Sciences, Yazd, Iran; 3Department of Anesthesiology, Paramedical Faculty, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 4Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 5Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 6Research Center of Addiction and Behavioral Sciences, Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, IranIntroduction: The decision to start insulin therapy is often difficult. Determining the barriers against insulin therapy initiation can facilitate care and treatment strategies. The aim of this study was to evaluate the barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran.Methods: This descriptive study was conducted on 214 patients referred to the Diabetes Center of Yazd University of Medical Sciences in 2015. Participants were randomly selected, and then they completed the insulin noncompliance questionnaire (20 questions). The percentage of adherence and the factors contributing to nonadherence to insulin therapy were analyzed using descriptive statistics, the Kruskal–Wallis test, and the Mann–Whitney test.Results: The most prevalent reason for insulin therapy refusal was expecting a new method of diabetes treatment (54.7%), followed by requiring someone else to administer the injection (19.2%), fear of needles, cost, traveling (18.7%), and stress/emotional problems (18.2%). Lack of trust in the physician was the least restrictive reason for nonadherence to insulin therapy.Conclusion: The most common reason given for insulin therapy refusal was the lack of adequate education. Therefore, specialized educational interventions can help minimize barriers and improve patients’ outcomes.Keywords: barriers, diabetes, insulin therapy, YazdShafie Pour MRSadeghiyeh THadavi MBesharati MBidaki RDove Medical PressarticleBarriersDiabetesInsulin Therapy. YazdSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 12, Pp 1349-1354 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Barriers Diabetes Insulin Therapy. Yazd Specialties of internal medicine RC581-951
spellingShingle	Barriers Diabetes Insulin Therapy. Yazd Specialties of internal medicine RC581-951 Shafie Pour MR Sadeghiyeh T Hadavi M Besharati M Bidaki R The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran
description	MR Shafie Pour,1 T Sadeghiyeh,2 M Hadavi,3,4 M Besharati,5 R Bidaki61Department of Internal Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 2Department of Psychiatry, Research Center of Addiction and Behavioral Sciences, Hahid Sadoughi University of Medical Sciences, Yazd, Iran; 3Department of Anesthesiology, Paramedical Faculty, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 4Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 5Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 6Research Center of Addiction and Behavioral Sciences, Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, IranIntroduction: The decision to start insulin therapy is often difficult. Determining the barriers against insulin therapy initiation can facilitate care and treatment strategies. The aim of this study was to evaluate the barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran.Methods: This descriptive study was conducted on 214 patients referred to the Diabetes Center of Yazd University of Medical Sciences in 2015. Participants were randomly selected, and then they completed the insulin noncompliance questionnaire (20 questions). The percentage of adherence and the factors contributing to nonadherence to insulin therapy were analyzed using descriptive statistics, the Kruskal–Wallis test, and the Mann–Whitney test.Results: The most prevalent reason for insulin therapy refusal was expecting a new method of diabetes treatment (54.7%), followed by requiring someone else to administer the injection (19.2%), fear of needles, cost, traveling (18.7%), and stress/emotional problems (18.2%). Lack of trust in the physician was the least restrictive reason for nonadherence to insulin therapy.Conclusion: The most common reason given for insulin therapy refusal was the lack of adequate education. Therefore, specialized educational interventions can help minimize barriers and improve patients’ outcomes.Keywords: barriers, diabetes, insulin therapy, Yazd
format	article
author	Shafie Pour MR Sadeghiyeh T Hadavi M Besharati M Bidaki R
author_facet	Shafie Pour MR Sadeghiyeh T Hadavi M Besharati M Bidaki R
author_sort	Shafie Pour MR
title	The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran
title_short	The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran
title_full	The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran
title_fullStr	The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran
title_full_unstemmed	The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran
title_sort	barriers against initiating insulin therapy among patients with diabetes living in yazd, iran
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/3482e4b07211459ebd9f284584131d49
work_keys_str_mv	AT shafiepourmr thebarriersagainstinitiatinginsulintherapyamongpatientswithdiabeteslivinginyazdiran AT sadeghiyeht thebarriersagainstinitiatinginsulintherapyamongpatientswithdiabeteslivinginyazdiran AT hadavim thebarriersagainstinitiatinginsulintherapyamongpatientswithdiabeteslivinginyazdiran AT besharatim thebarriersagainstinitiatinginsulintherapyamongpatientswithdiabeteslivinginyazdiran AT bidakir thebarriersagainstinitiatinginsulintherapyamongpatientswithdiabeteslivinginyazdiran AT shafiepourmr barriersagainstinitiatinginsulintherapyamongpatientswithdiabeteslivinginyazdiran AT sadeghiyeht barriersagainstinitiatinginsulintherapyamongpatientswithdiabeteslivinginyazdiran AT hadavim barriersagainstinitiatinginsulintherapyamongpatientswithdiabeteslivinginyazdiran AT besharatim barriersagainstinitiatinginsulintherapyamongpatientswithdiabeteslivinginyazdiran AT bidakir barriersagainstinitiatinginsulintherapyamongpatientswithdiabeteslivinginyazdiran
_version_	1718395811881025536

The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran

Ejemplares similares